TG Therapeutics Q4 2023 Earnings Preview

by
Contributor since / Followers

10 months ago

TG Therapeutics (NASDAQ:TGTX) is scheduled to announce Q4 earnings results on Wednesday, February 28th, before market open.
The consensus EPS Estimate is -$0.11 and the consensus Revenue Estimate is $40.06M.
Over the last 3 months, EPS estimates have seen 3

Tags: TGTX